#Leerink

Ionis Pharmaceuticals' 2026 Catalyst Pipeline: Implications for Stock Valuation

Leerink's recent adjustment of Ionis Pharmaceuticals' target price is influenced by the anticipated catalysts in the company's 2026 pipeline, which may enhance market performance.